Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Cash from Investing Activities data on file, last reported at -$172.7 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 2232.6% year-over-year to -$172.7 million in Q2 2026; TTM through Apr 2026 was -$203.3 million, a 772.13% decrease from a year earlier, with the FY2026 full-year figure at -$203.3 million, down 772.13% from the prior year.
• Cash from Investing Activities for Q2 2026 stood at -$172.7 million, down from -$14.9 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for KMTS reached as high as -$4.2 million in Q2 2024 and fell as low as -$172.7 million in Q2 2026.
• Historically, Cash from Investing Activities has averaged -$25.6 million across 3 years, with a median of -$7.4 million in 2025.
• Across the five-year window, Cash from Investing Activities fell 17.03% in 2025 and plunged 2232.6% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$4.4 million in 2024, then sank by 67.87% to -$7.4 million in 2025, then tumbled by 2227.57% to -$172.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$172.7 million in Q2 2026, -$14.9 million in Q1 2026, and -$7.4 million in Q4 2025.